408 results
Page 11 of 21
6-K
n7z k7ja9608jcn
2 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
nva1n 3tvs2d
2 May 13
Teva Reports First Quarter 2013 Results
12:00am
6-K
EX-99.1
ov9ijrilmawgf7 tly9r
1 May 13
FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and Over
12:00am
6-K
EX-99.1
6hn8w0sx bd1r
23 Apr 13
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402
12:00am
6-K
EX-99.1
2umid45ycx8ki
17 Apr 13
Data Reported Comparable Multiple Pregnancy Rates Among Patients Treated with Investigational Milprosa™ and Progesterone Vaginal Gel
12:00am
6-K
EX-99.1
t68yah7tj8xr 4e
29 Mar 13
Live Filing
12:00am
6-K
EX-99.1
bnu24v y2
21 Mar 13
Live Filing
12:00am
6-K
EX-99.1
mpn8abty6kq9 00aj7j3
20 Mar 13
Live Filing
12:00am
6-K
EX-99.1
no48 zv9ej1
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
7xyrs
6 Mar 13
Live Filing
12:00am
6-K
EX-99.1
8mamvipu18nlxijqqd
4 Mar 13
Live Filing
12:00am
6-K
EX-99.1
cczpvmjuwezr4xodak
22 Feb 13
Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting
12:00am
6-K
EX-99.1
z4gtcwwwuj p7
14 Feb 13
Live Filing
12:00am
6-K
EX-99.1
em9w 57qq8s
11 Feb 13
Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors
12:00am
6-K
EX-99.1
ygmb9gg
7 Feb 13
Teva Reports Fourth Quarter and Full Year 2012 Results
12:00am
6-K
EX-99.1
i2691hx
5 Feb 13
Teva Announces First Patient Enrolled In Largest Clinical Study to Date Evaluating Azilect® for Mild Cognitive Impairment In Parkinson’s Disease
12:00am
6-K
EX-99.1
p2n96x01u5 tpqpdy7f9
31 Jan 13
Teva Announces Termination of Agreements with Curetech
12:00am
6-K
EX-99.1
34wcaqnp024ghb1jss
23 Jan 13
Live Filing
12:00am
6-K
EX-99.1
bsalnl20wuvho68 puef
18 Dec 12
Live Filing
12:00am